James Chambers to Transfection
This is a "connection" page, showing publications James Chambers has written about Transfection.
Connection Strength
0.229
-
Ushigusa T, Koyama Y, Ito T, Watanabe K, Chambers JK, Hasegawa A, Uchida K, Kanegi R, Hatoya S, Inaba T, Sugiura K. Innate immunity mediated by dendritic cells/macrophages plays a central role in the early period in tumor treatment using gene of Mycobacterium tuberculosis antigen. J Vet Med Sci. 2018 Feb 09; 80(2):190-196.
Score: 0.140
-
Szekeres PG, Muir AI, Spinage LD, Miller JE, Butler SI, Smith A, Rennie GI, Murdock PR, Fitzgerald LR, Wu Hl, McMillan LJ, Guerrera S, Vawter L, Elshourbagy NA, Mooney JL, Bergsma DJ, Wilson S, Chambers JK. Neuromedin U is a potent agonist at the orphan G protein-coupled receptor FM3. J Biol Chem. 2000 Jul 07; 275(27):20247-50.
Score: 0.042
-
Trivedi NH, Yu JJ, Hung CY, Doelger RP, Navara CS, Armitige LY, Seshu J, Sinai AP, Chambers JP, Guentzel MN, Arulanandam BP. Microbial co-infection alters macrophage polarization, phagosomal escape, and microbial killing. Innate Immun. 2018 04; 24(3):152-162.
Score: 0.035
-
Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, Calamari A, Szekeres PG, Sarau HM, Chambers JK, Murdock P, Steplewski K, Shabon U, Miller JE, Middleton SE, Darker JG, Larminie CG, Wilson S, Bergsma DJ, Emson P, Faull R, Philpott KL, Harrison DC. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem. 2001 Aug 03; 276(31):28969-75.
Score: 0.011